ReviewCurrent cardiology reports2018
White Coat Hypertension and Cardiovascular Diseases: Innocent or Guilty.
Review in Current cardiology reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.
- Cardiovascular Events and Mortality in White Coat Hypertension: A Systematic Review and Meta-analysis.Annals of internal medicine · 2019Pooled it
- Nurse-Managed Hypertension Care in Primary Health Care Centers in Region Stockholm and Its Association With Blood Pressure Control and Key Indicators for Contractual Follow-Up.Journal of clinical hypertension (Greenwich, Conn.) · 2025Article
- A Metric Shedding Light on the Relationship Between White Coat Hypertension and Anxiety: The Hospital Anxiety and Depression Scale-Anxiety.Anatolian journal of cardiology · 2024Article
- Hemodynamic Changes Associated With Transcervical Laryngeal Injection of Botulinum Toxin.Journal of voice : official journal of the Voice Foundation · 2023Article
- Reproducibility and Predictive Value of White-Coat Hypertension in Young to Middle-Age Subjects.Diagnostics (Basel, Switzerland) · 2023Article
- Impact of Uncontrolled Hypertension at 3 Months After Intracerebral Hemorrhage.Journal of the American Heart Association · 2021Article
- Association of circulating miR-155 expression level and inflammatory markers with white coat hypertension.Journal of human hypertension · 2020Article
- Effects of white-coat, masked and sustained hypertension on coronary artery stenosis and cardiac arrhythmia.Hypertension research : official journal of the Japanese Society of Hypertension · 2020Observational
- Long-Term Risk of Progression to Sustained Hypertension in White-Coat Hypertension with Normal Night-Time Blood Pressure Values.International journal of hypertension · 2020Article
- White-coat hypertension: management and adherence to guidelines by European and Canadian GPs. A cross-sectional clinical vignette study.BJGP open · 2019Article
- A working definition of white-coat hypertension must include nocturnal blood pressure.Journal of clinical hypertension (Greenwich, Conn.) · 2018Article
- Stress, Genes, and Hypertension. Contribution of the ISIAH Rat Strain Study.Current hypertension reports · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThis review aims to clarify the cardiovascular risk of white coat hypertension (WCH). RECENT
findingsCardiovascular risk of WCH has been evaluated in multiple meta-analyses and population-based studies. International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes study evaluated the cardiovascular risk in 653 patients with WCH and 5137 normotensive patients. The patients were age-matched and were followed for 10.6 years. The results revealed no increased cardiovascular risk except in older high-risk WCH patients. A recent meta-analysis evaluated the cardiovascular risk in WCH subjects without any antihypertensive treatment (23 cohorts, 20 445 individuals), WCH subjects with antihypertensive treatment (11 cohorts, 8656 individuals), and mixed population including both treated and untreated subjects (12 cohorts, 21 336 individuals). This study revealed increased cardiovascular risk in untreated and mixed population WCH subjects but not in treated WCH subjects. WCH might have prognostic impact on cardiovascular outcomes; however, this is not true in all WCH subjects. Further studies should identify the subgroups of WCH that are at increased risk and evaluate the effect of therapeutic measures on cardiovascular outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.